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The release of the latent substructures requires the coordination of a complex set of proteinases and the challenging comprehension of these phenomena is just at the beginning. In vitro studies are often meaningless because cascades of fragmentation generated in vivo by specific molecular interactions cannot be reproduced with reliability in simplified artificial systems. These fragmentation cascades cannot be investigated neither by bottom-up nor by middle-down proteomic platforms for their intrinsic limitation to discern the peptides naturally occurring from those generated in the sample by the digestion preceding the analytical step [4] . The only viable strategy is the application of top-down proteomics, which has the demanding purpose to elucidate the structure of intact proteins/peptides [5] . This review describes some results obtained for the characterization of human peptides in different bodily fluids by top-down platforms, in particular underlying the studies devoted to the investigation of the roles and the potential application of the identified peptides. The current huge amount of information obliged to select the most significant data reported in literature and we apologize for many relevant omissions.
Blood, plasma and serum
Blood is a complex liquid tissue including a corpuscular and a non-corpuscular fraction and represents the major connection between cells and tissues of an organism, allowing transport of both oxygen, molecules (i.e. hormones, amino acids, carbohydrates, lipids, vitamins, mineral salts and water) and metabolic waste products.
The proteome/peptidome of a blood sample is directly linked to the metabolic state and can provide information on the physiological and/or pathological processes occurring in the body. The proteins and peptides present in serum and plasma, the non-corpuscular blood fractions, are a combination of those playing circulatory functions and those secreted or released into the circulation from cells during both normal biological events and in diseases [6] .
Being the most available clinical samples, serum and plasma represent a convenient source of potential diseasebiomarker peptides with minimal invasiveness. Naturally occurring peptides typically derive from cleavages of the most abundant full-length proteins as a result of numerous proteases activity contained in these fluids or produced by cells [7, 8] .
As reported, a high number of peptides is only present in serum and not detectable in plasma. In fact, more than 40% of the peptides detected in serum are generated by ex vivo processes during specimen collection and preparation, introducing peptide signals which have to be interpreted with prudence [9] . Serum generation is associated with coagulation cascade and activation of complement system. These processes involve cell lysis and proteinases activation leading to the production of numerous peptides from proteins cleavages. Moreover, peptides are released from blood clot during the specimen collection [i.e. thymosin β 4 (Tβ 4 ), zyxin]. In plasma preparation, the addition of chelating agents deeply stabilized the protein/ peptide composition [9, 10] . However, for several clinical analyses serum is preferred because anticoagulants can sometimes interfere with the results. Whatever the fluid, peptidomic analysis of serum and/or plasma is critical due to the wide range of protein and peptide concentrations that spans over ten orders of magnitude [9] . For this reason in 2002 the Human Plasma Proteome Project (HPPP) of the Human Proteome Organization started with the aims to standardize protocols of specimens collection, handling and storage [9, 10] , stimulating the use of emerging technologies, sharing results and creating global, opensource databases repository [11, 12] .
Pre-treatment of serum and plasma samples for top-down peptidomic analysis is particularly critical due to the high complexity of these biological samples, the large span of molecular weight distribution of peptides and the biological variability (i.e. gender, age, genetic, environmental, dietary, and psychological factors) [13] . Several pre-treatment strategies have been proposed for enrichment of blood peptides and removal of high abundance proteins: i) centrifugal ultrafiltration at low speed and in denaturing conditions; ii) protein precipitation with organic solvent (acetone or acetonitrile), and; iii) cleaning-up with solid phase extraction (SPE) columns, magnetic beads and disk plates. All these procedures may or not be followed by a further fractionation step [SPE strategies, gel electrophoresis, surface-derivatives chips or beads, filtration with nanoporous substrates, capillary electrophoresis (CE) and liquid chromatography (LC)] [14] [15] [16] [17] [18] [19] . An interesting recent paper compares methods designed to remove intact proteins from plasma in order to allow analysis of the peptidome by liquid chromatography-mass spectrometry (LC-MS) experiments [20] . The authors introduced the use of Mass differential Tags for Relative and Absolute Quantification (mTRAQ) labeling coupled to Selected Reaction Monitoring assay to monitor each peptide and determine the peptide recovery, thus evaluating the suitability of each method. Other papers reported the development of mass spectrometry based quantitation methods for peptides analysis in serum [21] and plasma [16] .
Small blood peptides are often the results of physiological or pathological processes within cell involving protease activities: both as waste products or signal molecules they may hide a powerful role of diagnostic biomarker panel [7] . Therefore, many studies are devoted to identify and quantify blood peptidome patterns, in particular for biomarker discovering.
Richter et al. [22] identified plasma peptides in extracts of human hemofiltrate generating a mass database and a sequence database with approximately 5000 peptides deriving from over 340 sequence entries of 75 different protein precursors: 55% are plasma proteins [albumin, fibrinogen A (RGD peptides), fibrinogen B, α-1-microglobulin, β-2-microglobulin, zinc-α-2-glycoprotein, α -2-HS-glycoprotein, serum amyloid A protein, haptoglobin, profilin, vitronectin, desmocollin, Tβ 4 Amyloid-β (Aβ) peptides are among the most challenging peptides in blood, because of their strict relation with Alzheimer disease (AD), which is the most common neurodegenerative disorder. As is largely known, these peptides normally derive by the sequential cleavage of the amyloid precursor protein, and, when overproduced, progressively aggregate as small neurotoxic oligomers in the brain, leading to severe cortical dysfunction. The Aβ variants circulating in plasma are Aβ and Aβ and it has been suggested that these peptides are transported into the brain via blood circulation [23] . Many studies are focused on the development of effective analytical method for the detection of Aβ peptides [23, 24] , possible candidates as plasma biomarkers for prediction, progression and therapeutic monitoring of the AD. However, to date the results are not completely clear and in some cases they don't correlate each other [25, 26] . In addition to Aβ peptides, Hu et al. [27] reported that pancreatic polypeptide and B-type natriuretic peptide were strongly associated with the diagnosis of mild cognitive impairment and AD states. Moreover, plasma levels of these two peptides correlated with cerebrospinal fluid (CSF) Aβ 1-42 levels and t-tau/Aβ 1-42 ratio, well-known CSF AD biomarkers, and thus could serve as the basis of a plasma-based screening battery for AD.
Another peptide found in blood that has multiple amazing functions is Tβ 4 , the main G-actin binding acetylated peptide present in almost any tissue and in extracellular media in mammals. In blood it is present in the cytoplasm and nucleus of all cells (except erythrocytes) and in plasma and serum [28] . It is surprising that a molecule as small as Tβ 4 contains so many biological and structural functions such as wound healing, stimulation of angiogenesis and suppression of inflammation [28] . Its concentration in serum and in plasma corresponds to about 1% of the total amount of Tβ 4 present in whole blood, while its intracellular concentration in leukocytes including platelets is above 300 μM [29] . In blood coagulation or ADP-induced platelets aggregation, Tβ 4 is released from platelets and partially cross-linked to fibrin. Its linking to the fibrin clot might represent a mechanism to guarantee a high local concentration of the peptide at the site of the injury, probably supporting subsequent wound healing processes [29] . It has been shown that extracellular Tβ 4 induces migration of cardiomyocytes and their survival as well [30] . In addition to intact Tβ 4 , the N-terminal tetrapeptide (AcSDKP) and larger C and N-terminal fragments show several biological activities and are related to different pathological states [31] [32] [33] [34] . For instance, serum samples from psoriasis patients exhibited altered levels of Tβ 4 proteolytic peptides 1-17, 22-43 and 25-45 [33] , while plasma samples from patients with rheumatoid arthritis [34] showed that Tβ 4 actin binding site (LKKTETQ) was cleaved by the combined action of endoproteases and amminopeptidases to generate Tβ 4 peptide ladders (fragment 19-43, 20-43, 22-43, 23-43, 24-43, 25-43, 26-43, 30-43) . In both cases the levels of proteolytic peptides are increased with respect to control samples, and it has also been found that concentration of certain peptides was much higher in the disease states (i.e. fragment 25-43 and 22-43) .
Many recent papers are focused on serum/plasma peptidome patterns of patients affected by several cancer diseases [15] (i.e. brain tumors [35] , thyroid carcinoma [36] , pancreatic cancer [37, 38] , breast cancer [39] , prostate cancer [40] , multiple-myeloma and leukemia [41] , and lung adenocarcinoma [42] ). It has been suggested that different tumors secrete distinct proteases generating unique serum peptide profiles [40] . In metastatic thyroid carcinoma [36] 12-peptide thyroid cancer signature was obtained with respect to control samples. Ten of them had been previously assigned to other tumors [40] , while one of the two newly identified peptides is a 54-amino acidlong fibrinogen-α fragment.
In serum peptidome profiling of pancreatic cancer have been found decreased levels of platelet factor 4 with respect to normal samples [37] . Platelet factor 4 is a member of C-X-C chemokine family and its decrease could suggest an enhancement of metalloproteinase activities due to their up-regulation. A work conducted on pooled plasma samples from 15 breast cancer patients [39] showed that breast cancer and control samples had very similar sets of plasma proteins identified by the conventional bottom-up proteomic method, but different degradation patterns obtained by top-down peptidomic analysis. In particular, breast cancer sample displayed 839 distinct peptides versus the 425 peptides detected in healthy controls. Furthermore, the degradation observed was substrate selective and for individual substrates the cleavage specificity could vary significantly (for instance in the case of apolipoprotein A-IV) [8] . This finding suggests a significantly higher degradome activity in cancer and differences of the substrate proteolytic activity in the physiological and pathological states.
In the lung adenocarcinoma serum peptidome profile, 12 peptide candidates have been suggested as cancer biomarkers [42] . Among them, eight are reported as fibrinopeptide A (FPA) and FPA derived peptides In summary, plasma and serum top-down peptidomic analysis could represent a powerful strategy for the comprehension of biological processes, such as signal transmission between cells, circulation and transport of several molecules and development of diseases. The identification of serum/plasma biomarker diseases, especially cancer disease, is the first goal of all the research laboratories involved in the Plasma Proteome Project of the Human Proteome Organization [12] .
Urine
Because of its easy, non-invasive and non-painful collection, large availability and stability, urine is one of the most suitable bodily fluids for the analysis of peptides compared to other biological matrices.
The urinary proteome is distributed among the soluble fraction, the "sediments" (principally consisting in epithelial cells and debris), the small membrane fragments and the "exosomes" (small vesicles excreted from cells facing the urine) [43] . As a consequence of urine origin, its peptidome is principally made up of small soluble peptides which derive naturally from plasma, either excreted by several mechanisms from kidneys and urogenital tract or produced by proteolytic activity of extracellular proteases. Therefore the peptidome and proteome of urine, kidney and plasma are strictly correlated [44] . Perturbation of urinary peptide fraction can occur in different disease states resulting in alteration of the urinary peptidomic profile and/or increased urinary peptide excretion [45] . In normal donors the protein content of urine is lower than 100 mg/L, however the urinary proteome and metabolome is highly variable as a consequence of different daily intake of fluids, diets, metabolic processes and circadian rhythms [46, 47] . Recently, a new fingerprint database of human urinary proteome was developed to facilitate the use of this biofluid as a source of diagnostic biomarkers [48] . The availability of large amount of sample allows easily operating an adequate peptide concentration for MS analysis without additional manipulation (top-down proteomic platform). The most employed techniques for urine peptidomic analysis by top-down approach are CE-MS [49] [50] [51] [52] , surface-enhanced laser desorption/ ionization (SELDI)-time of flight (TOF) MS [53] and matrixassisted laser desorption/ionization (MALDI) [54] , also in association with metal microsphere peptide enrichment [55] and evaluating the important contribution of sample dilution for calculation of peptides relative abundance [56] . Compared to LC-MS [57] [58] [59] these three techniques are more suitable for easy and fast analysis of low amount of samples (few microliters). Up to now over 2000 proteins and 100000 peptides have been detected in urine [46, 58, 60] , and, thanks to its easy manipulation and accessibility, this biological fluid is one of the most used for biomarker discovery.
The increase of urinary peptides levels is observed in patients with proteinuria [61] and up to the 20-30% of them originated from serum albumin fragmentation. These peptides, normally undetectable in healthy subjects, could suggest the presence of an increased protease activity in these patients [62] . The detection of proteinuria/albuminuria is commonly used in clinics for the diagnosis of renal damage, however, these symptoms are not specific and frequently a late manifestations of the disease. Therefore, urinary biomarker peptides can allow, together with the assessment of kidney damage, also differential diagnosis of specific chronic renal diseases (diabetic nephropathy, IgA nephropathy, systemic vasculitis etc.) and their progression status, nephrological disorders (i.e. urotheliasis, renal transplant rejection, ureteropelvic junction obstruction, cancer related to urogenital system) and non-nephrological/urogenital pathologies (preeclampsia, coronary artery disease, heart failure, stroke, graft-versus-host disease, etc.) [57] . CE-electrospray ionization (ESI)-TOF was applied for top-down peptidomic analysis of urine collected from individuals affected by different forms of chronic kidney diseases in comparison with control patient samples [49] . In particular, in chronic kidney disease, the increase of serum proteins fragments (i.e. serum albumin, fibrinogen and α 1 -antitrypsin, hemoglobin α chain, etc.) and the decrease of diverse collagen fragments (especially from collagen α-1 chain) and kidney-proteins (i.e. uromodulin, sodium/potassium-transporting ATPase γ chain, membrane-associated progesterone receptor component 1) were found. In an another study involving patients affected by type 1 diabetes, microalbuminuria and early renal failure [63] , showed the urinary decrease of three peptides fragments of α-1 (IV) and α-1 (V) collagens and tenascin-X, and the increase of three fragments of inositol pentakinophospate 2-kinase, zona occludens 3 and FAT tumor suppressor 2, with respect to controls.
CE-MS analysis of urine samples allowed also defining a specific peptide pattern for diagnosis and risk stratification in autosomal dominant polycystic kidney disease (ADPKD) [64] . The developed diagnostic biomarker model was based on 142 peptides, including markers previously associated with acute kidney injury, and demonstrated to be highly specific for ADPKD.
Ling et al. [65] developed a top-down MS based method for a non invasive diagnosis of rejection of renal allografts. MALDI-TOF/TOF and linear trap quadrupole (LTQ)-Orbitrap analyses identified 40 urine peptides specific of acute rejection and LC-ESI-triple quadrupole (Q-q-Q) in multiple-reaction monitoring scan mode allowed their quantification. These peptides belonged to nine different proteins, eight of collagen family (fragments of α-1 (I), α-1 (II), α-3 (I), α-4 (III), α-4(IV), α-4 (V), α-7 (I), α-18 (I) collagens) and one of uromodulin. The analysis of the peptide sequences evidenced a specific proteolytic degradation of collagen and uromodulin during renal allografts acute rejection.
Pèrez and co-workers [66] studied the effect of the paracalcitol treatment on urinary peptidome in kidney transplant patient. Paracalcitol, a selective vitamin D receptor activator, generally used in prevention and treatment of hyperparathyroidism, was recently associated with improved prolonged survival in these patients. Magnetic bead technology in coupling with MALDI-TOF fingerprinting mass spectrometry identified a significant alteration of the quantity of selected urinary peptides after 3 months of paracalcitol treatment, useful for the elucidation of the possible molecular mechanism associated with drug administration.
Many studies were devoted to the identification of urinary biomarkers for diagnosis, disease progression, recurrence and treatment response of cancer urogenital disease [67] [68] [69] [70] . Theodorescu et al. [67] found a pattern of 22 polypeptides molecular masses as urothelialcarcinoma urinary biomarkers; among them one of the most relevant is FPA. In fact, it has been demonstrated that the activation of coagulation pathways has a role in the preclinical phase of cancer and is associated with an increase of malignancy [71] . The same research group discovered and validated urinary biomarkers for prostate cancer (fragments of collagen α-1 (III) chain, collagen α-1 (I) chain, psoriasis susceptibility 1 candidate gene 2 protein, sodium/potassium-transporting ATPase γ chain) [68] and for the prediction of non muscle invasive bladder cancer (fragments of uromodulin, collagen α-1 (I), collagen α-1 (III), and membrane-associated progesterone receptor component 1) [69] .
Very recently, 86 urinary peptides (40 out of them sequenced) were associated with renal cell carcinoma as biomarker panel with a specificity of 87% [70] . Urinary proteomic analysis was able to differentiate cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders by the identification of a panel of peptides mostly of them identified as fragments of interstitial collagens of both renal and extra-renal origins [72] .
Significant variations of the peptidomic profile were also found in urine of patients with non-nephrological/ urogenital diseases. Ling et al. [73] identified a panel of 17 peptide biomarkers that could discriminate the different stages of systemic juvenile idiopathic arthritis (SJIA). The early diagnosis of this disease is difficult therefore delaying an appropriate therapy. These peptides were identified as degradation products of eight different proteins: α-1 antitrypsin, collagen α-1 (I) (five peptides and three of them having overlapping sequences), collagen α-2 (I), collagen α-1 (III) (one peptide), collagen type α-2 (IX) (one peptide), fibrinogen α (two peptides having overlapping sequences), fibrinogen β (two peptides having overlapping sequences), and uromodulin (three peptides having overlapping sequences).
A peptide generated from the degradation of isoform 1 of fibrinogen α chain precursor able to differentiate between positive and negative Helicobacter pylori infected volunteers was identified in urine by MALDI-TOF and characterized by LTQ-Orbitrap tandem MS analysis [74] .
Top-down proteomic analysis by MALDI-TOF was also applied to investigate the alteration induced by different altitudes (a model to explore diseases related to tissue hypoxia) in combination with Telmisartan pharmacological treatment [75] . The results showed that the peptidome did not change with Telmisartan administration but only in relation to altitude exposure. In particular, in subjects with hypobaric hypoxia six different peptides have been detected differently expressed, two of them belonging to uromodulin and to α-1 antitrypsin.
Urinary proteomic analysis was able to discriminate patients with coronary artery disease from healthy individuals by the identification of a peptide biomarker panel including fragments of collagen type 1 and 3, fibrinogen α-chain, sodium/potassium transporting ATPase gamma chain, α-1-antitrypsin, granin-like neuroendocrine peptide precursor and membraneassociated progesterone receptor component 1 [76] .
As mentioned till now, urinary peptidomics is a useful tool for the individuation of molecular biomarkers of prognosis and diagnosis of several urogenital and nonurogenital diseases, as deriving from specific proteolytic cleavages of both plasma and kidneys proteins. However, it is noteworthy to underline that some of the identified peptides biomarkers in urine are associated to different pathologies. For instance, the peptide DGApGKNGERGGpGGpGP [a degradation product of collagen α-1 (III)] is present both in urine of ADPKD and SJIA, although the two diseases have different pathogenesis: specifically, ADPKD is an hereditary kidney disease, caused by mutations in the PKD1 or the PKD2 genes, while SJIA is a chronic inflammatory disease of childhood characterized by a combination of systemic symptoms [fever, rash, serositis (e.g., pericarditis, pleuritis)] and arthritis. Further studies are surely necessary in order to establish validation, clinical specificity and sensitivity of all the urinary biomarkers already identified.
Cerebrospinal Fluid
The cerebrospinal fluid (CSF) is a colorless liquid that surrounds the brain and the spinal cord. It has several functions including mechanical protection, metabolites/ waste products circulation and central nervous system (CNS) homeostasis regulation [77] . CSF is secreted from several different components of the CNS, in particular, from the choroid plexus localized within lateral ventricles, roof of the III ventricle and floor of the IV ventricle. In the human ventricular system, the CSF total volume is 125 ml, with a daily production of 500 ml in adult and child, while this value is significantly lower in newborns [78] . CSF formation is the result of either blood ultrafiltration, through the fenestrated capillaries endothelium and choroid epithelium of ependyma, either brain tissue contribution and it is characterized by the presence of electrolytes, glucose, amino acids, peptides, proteins and metabolites. Although the protein composition of CSF is very similar to blood, the total protein concentration is about 200 times lower. Furthermore, as a consequence of the blood brain barrier filtration, same components are present in a different ratio in the two biofluids, resulting in a diverse distribution pattern of the most abundant proteins [77] .
Due to the close contact with brain tissues, CSF analysis offers an exclusive opportunity for studying CNS related diseases and biomarker discovering. Particularly, significant differences have been found in CSF proteome and peptidome in association to diverse CNS diseases, indicating the high potential of CSF for biomarkers identification: proteins and peptides usually absent in CSF can be present in a pathological state as a consequence of a blood brain barrier damage or to a local production (neurodegenerative/tumoural diseases) [79] .
The proteomic analysis of human CSF has been extensively reviewed [77, 78] particularly focusing on neurodegenerative disease biomarker discovery [80] . Being biomarkers mainly represented by small proteins and peptides (molecular weight less than 10 kDa), the top-down approach for CSF peptidomics is a successful strategy for identifying their candidates and studying CNS pathologies, as following described.
As for the other biofluids the conditions of storage and treatment of cerebrospinal fluid are crucial to maintain the intact protein state for top-down proteomic analysis. The immediate storage of the sample at -80°C and/or the immediate treatment (i.e. centrifugation) are essential for preserving the original characteristics and inhibiting protease activity [81] . A recent study, evaluating the entity of protease activity during cerebrospinal fluid, serum and plasma sample handling, observed no significant activity of the endogenous enzymes, during an appropriate time, confirming the power of top-down proteomics for biomarker discovering and suggesting an intrinsic protective role of the sample from degradation [82] . Nano-LC in coupling with Q-TOF-MS was used for peptidomic analysis of human lumbar CSF, after removal of high molecular mass proteins and salts and solid phase cartridge enrichment, focusing on identification of low molecular mass (<5 kDa) peptides originating from in vivo enzymatic cleavage of large proteins [83] . The top-down platform was successfully applied for the identification and sequencing of peptides with molecular mass lower than 3 kDa, while trypsin digestion was necessary for the identification of bigger peptides and proteins. Six different naturally occurring peptides belonging to fibrinogen α/α-E chain precursor and three belonging to prothrombin, granin-like neuroendocrine peptide and fibrinogen β-chain precursors, respectively, were characterized. Another research [84] demonstrated the high potential of nanoESI-Q-TOF-MS instrumentation for characterization and sequencing of peptides within 9 kDa in human lumbar CSF and brain tissue with topdown approach after LC pre-fractionation and MALDI-TOF-MS identification, following the procedure previously described for CSF high resolution peptide mapping [85] . In this work Tβ4, the neuropeptide hormone NPY (4.3 kDa) and ubiquitin (8.5 kDa) were sequenced together with a series of peptides in the range 1-9 kDa belonging to 13 different precursor proteins, i.e. α-1-antitrypsin, albumin, cholecystokinin, chromogranin A, fibrinogen α, glyceraldehyde-3-phosphate-dehydrogenase, haemoglobin β-chain, neuroendocrine specific protein VGF, osteopontin, ProSAAS, secretogranin I and II and transthyretin.
The first study presenting an extensive proteomic and peptidomic characterization of human lumbar CSF on large scale appeared in 2008 [86] . CSF was analyzed after dithiothreitol reduction and iodoacetamide alkylation followed by ultrafiltration: the high molecular weight fraction (proteome) was studied by LC-MS/MS in bottom-up approach, following 1D gel separation and trypsin digestion, while the low molecular one (peptidome) was directly analyzed by capillary LC-nano-ESI-LTQ-Orbitrap in top-down strategy using Higher-energy Collisional Dissociation fragmentation mode. Several PTMs were present on the characterized neuropeptides. Most of the identified peptides were generated by cleavage of larger precursor proteins and probably for a specific biological activity purpose: the C-terminal amidated joining peptide, neurexophilin-3 and -4 peptides with pyroglutamic acid at N-terminal glutamine, synaptogamins and phospholemman peptides with different PTMs, cystein rich paragranulin-like peptide, Insulin-like growth factor-2 glycosylated peptide, glycosylated heparinbinding EGF-like growth factor and orexin-A peptides and polyproline peptides were some examples. Several PTMs were present on the characterized neuropeptides. A comprehensive study of CSF peptidomics appeared subsequently [87] . Ultrafiltration procedures by molecular weight cut-off filters with or without previous treatments of CSF with acetonitrile and/or formic acid were applied and compared for peptide identifications in the range 700-5000 Da by nanoLC off line coupled to MALDI-TOF-MS. With respect to ultrafiltration only, the treatment of CSF with 20% of acetonitrile resulted in an increased number of detected peptides from 2445 (untreated CSF) to 3543. Not considering the occurrence of PTMs, tandem MS analysis identified 625 unique peptides sequences originating from 104 proteins.
Most of the peptidomic analysis of CSF was devoted to study Aβ peptides in relation to neurodegenerative diseases. To this regard, the analysis of the peptides in their entire state is of importance for the identification of PTMs events that could be of relevance for studying and diagnosing neurodegenerative diseases. CSF is an effective source of candidate peptide biomarkers for AD as reviewed in recent papers [25, 88] . Aβ peptides were in principle mainly analyzed by immune-based technologies. SELDI-TOF-MS was applied to Aβ peptide characterization in CSF in relation to AD after protein chip affinity array [89] . The comparison with Sodium Dodecyl Sulphate-Polyacrylamide Gel Electrophoresis (SDS-PAGE) immunoblotting data established the high potential of SELDI-MS for expression profiling of the neurodegenerative disease: the identified Aβ peptides showed different patterns in AD CSF with respect to controls and the exclusive presence of Aβ 2-46 in AD sample was outlined. Another study using the same procedure investigated Aβ peptides distribution in AD CSF sample and healthy control of the same range of age providing similar results [90] .
Portelius et al. described a MALDI-TOF-MS method in reflector mode [91, 92] and nanoLC-LTQ-FT tandem MS [93] for Aβ peptides analysis in lumbar CSF after immunoprecipitation with monoclonal antibody bound to magnetic beads. They identified N-and C-terminal truncated Aβ peptides, particularly Aβ 1-16 , Aβ 1-33 , Aβ and Aβ (some exhibiting oxidized methionine inside the sequence), showing a different pattern between pathological samples and healthy control. In this work the use of isotopically labeled internal standard minimized the variation induced by sample preparation and analysis allowing the potential development of a future diagnostic tool. MALDI-TOF-MS analysis of lumbar CSF from the same group of authors allowed distinguishing sporadic AD patients from normal and depressed individuals and familiar AD patients by the individuation of aberrant Aβ peptides pattern and isoforms [94] . A novel separation and detection method for amino-terminal Aβ peptides variants in human CSF in association with MS identification after immunoprecipitation was also recently developed [95] .
In a recent paper a new ultra performance LC method in coupling with Q-q-Q MS in Multiple Reaction Monitoring mode was developed and validated for the quantitative analysis of Aβ 1-38 , Aβ and Aβ in CSF after SPE [96] . A CE method was also developed for analyzing five amyloid peptides of relevant clinical interest in CSF [97] .
A novel procedure for analyzing CSF peptidome was recently described applying two schemes for the isolation of different peptide and protein fractions in post-mortem samples of AD patients [98] . Low molecular weight peptides were analyzed in the soluble fraction after precipitation with a mixture of methanol and chloroform. The pellet was re-solubilized, and after reduction/amidation re-precipitated: the resulting supernatant was submitted to analysis of the peptides released from high molecular weight proteins. The pellet was enzymatically digested for protein identification. Both the peptide fractions were analyzed by MALDI-TOF-TOF and nanoLC in coupling with Ultra High Resolution-TOF-MS. Peptides belonging to VGF nerve growth factor inducible, complement C4 precursors and peptides of α-2-HS-glycoprotein were able to discriminate AD patients from controls. Recently, SELDI-TOF-MS was applied to CSF analysis of Aβ peptides in association to cognitive decline in sporadic AD and elderly schizophrenic patients showing a distinctive signature [99] .
The proteomic analysis of lumbar CSF of amyotrophic lateral sclerosis (SLA) patients revealed interesting alterations with respect to controls allowing the identification of potential disease biomarker and evidencing the possible mechanisms involved. The samples were analyzed by MALDI-TOF-MS after superparamagnetic particle isolation and by LC-ESI-LTQ tandem MS for peptides identification [100] . Immunoprecipitation in coupling with mass spectrometry of undigested CSF was used to study the alterations of amyloid precursor protein and Aβ peptide levels in multiple sclerosis patients also revealing at this level the counteraction of natalizumab treatment [101] . Few papers deal with CSF peptidomics in relation to brain cancer diseases. A recent review outlined the state of art of proteomic analysis applied to gliomas starting from different biological matrices including CSF. However, this study highlighted more bottom-up than topdown applications [102] .
Top-down proteomic by our group recently identified in CSF a panel of bioactive peptides of hemoglobin origin, including LVV-and VV-hemorphin-7 and other four peptides with sequence homology to α-and β-globin chains fragments, as candidate biomarkers of prognosis of posterior cranial fossa pediatric brain tumor diseases [103] . Ventricular CSF was collected intra-operatively and post-operatively from the same patients and analyzed by LC in coupling with high resolution ESI-LTQ-Orbitrap mass spectrometry in Data Dependent Scan after a simple pretreatment procedure, outlining the importance of top-down proteomics. A selective method for LVV-and VV-hemorphin-7 quantitation in CSF was also specifically developed and validated by CE-ESI-ion trap-MS starting from few biofluids volume after a simple sample pretreatment [104] .
A biomarkers peptides panel of prospective diagnostic application of different neurodegenerative diseases was identified by peptidomic analysis of lumbar CSF in top-down approach by CE-TOF-MS [105] . Of the about 1000 polypeptides measured, 279 were identified by the combination of CE-MS data software elaboration and high resolution MS de novo sequencing.
Saliva and gingival crevicular fluid
Human saliva is a bodily fluid secreted by three couples of major glands (parotid, submandibular and sublingual glands) and by an individually variable number of minor salivary glands [106] . The term "saliva" usually refers only to the fluid secreted by these glands and is the main issue of this section, while the term "whole saliva" or "oral fluid" refers to a more complex solution comprising oral exudates, gingival crevicular fluid, oral microflora, desfoliating cells, nasal secretion and food remnants [107] . Peptides present in glandular saliva at first originate from a complex secretion process starting in acinar cells, where many pre-pro-proteins are submitted to cleavages, after the loss of the signal peptide, generating a great number of smaller peptides [108] . In some cases the process is exhaustive, as for basic proline-rich proteins (bPRPs), which are not detectable in saliva as pro-proteins [109] . Acidic proline-rich proteins (aPRPs), on the contrary, can be detected simultaneously as intact pro-proteins (PRP-1, PRP-2, PIF-s, Db-s, Pa as different possible isoforms) and as fragmentation products (PRP-3, PRP-4, PIF-f, Db-f and the P-C peptide, 44 a.a. residue long, common to all aPRPs) [110] . Glandular "saliva" contains some specific salivary peptide families too, named histatins (Hst), statherins and PB peptide. Histatins are a family of small histidine-rich peptides, some of them with interesting antifungal activity [111] . It is widely accepted that all the members of this family arise from two parent peptides, Hst 1 and Hst 3, having very similar sequences and encoded by two genes (HIS1 and HIS2) . Despite the very high sequence similarity, these two peptides follow completely different PTM pathways [106] . Hst 3 is submitted to a pre-secretory sequential cleavage generating at first Hst 6 (histatin 3 1/25), subsequently Hst 5 (histatin 3 1/24) and then other fragments [112] . Hst 1 is not cleaved during secretion for the absence of a proper consensus sequence. Hst 1 is phosphorylated on Ser-2 residue, while Hst 3 is not, due to the absence of a +2 flanking glutamic acid residue to Ser-2 essential for the kinase recognition. Hst 1 is partly polysulfated on the four terminal tyrosines in submandibular glands, differently from Hst 3, which lacks a tyrosine equivalent to Tyr-27 of Hst 1 probably essential for the tyrosylprotein sulfotransferase recognition [113] . Statherin is an unusual tyrosine-rich phospho-peptide of 43 residues which should be related to the modulation of oral calcium concentration. Many properties of P-B peptide suggest a functional relationship with statherin, although no specific function of this peptide have been proposed to date [114] . All this informations have been recently investigated by High Performance Liquid Chromatography (HPLC)-ESI-MS top-down platforms [115] .
All the salivary peptides above reported are submitted, after secretion, to further cleavages, generating a great number of different fragments. Top-down HPLC-ESI-MS analysis revealed that the proteolytic cleavage generating these fragments occurred preferentially after a glutamine residue with a predominant specificity for a XPQ, where X in the -3 flanking position is mainly represented by a lysine residue [116] . Systematic evaluation of the enzyme activity responsible for these cleavages revealed the presence of a glutamine endoprotease exogenous in origin, deriving from different Rhodia strains, common hosts of dental plaque [117] . The Rhodia enzymes have the ability to degrade gluten proteins and recent researches are trying to investigate if they can neutralize gluten epitopes [117] .
Despite the efforts until now performed, many questions on the functions of these peptides and their fragments remain unresolved. Statherin and aPRPs are surely involved in oral calcium homeostasis [106, 107] , but no hypothesis exists about the role of both the aPRPs fragmentation and P-C and P-B peptides. Hst 3 and their fragments (especially Hst 5 and 6) display noticeable antifungal and antimicrobial activity [118] . Surprisingly, recent studies have demonstrated that, even though its structural similarity with Hst 3, Hst 1 differently displayed interesting wound healing properties [119] . Nto C-cyclization potentiated the peptide activity 1000-fold, indicating that a specific peptide conformation was responsible for the effect [120] . The minimally active domain was fragment 20-32 of the parent peptide. Interestingly, Hst 1 stimulated wound closure of primary cells of both oral and non-oral origin [121] , which encouraged the therapeutic application of Hst 1-derived peptides in the treatment of different kinds of skin wound.
Little information is available on the potential role of bPRPs and fragments, except their hypothetical ability to protect against the harmful effects of tannins [122] . However, because recent studies have shown that full expression of bPRPs is reached after puberty [123] , it is evident that they should exert age-linked functions. For instance, recent studies have demonstrated their potential role as mediators of bitter taste perception [124, 125] . Moreover, some bPRPs fragments show potential antiviral activity [126] .
HPLC-ESI-MS top-down platforms have recently established that other naturally occurring fragments of bigger proteins are detectable in human whole saliva, such as some fragments of glycerhaldeide-3-phosphate dehydrogenase and polymeric Ig receptor [115] , but no further information is available about their significance in the oral cavity.
Recent studies carried out with top-down platforms are indicating that some variations of the concentration of these peptides, of their PTMs and/or of naturally occurring fragments could be utilized as biomarker or clues of multifactorial diseases. Anomalous fragment levels from different peptides (P-C, P-B, statherin, histatins) were established in Type 1 (insulin dependent) diabetic patients [127] where a simultaneous decrease of the concentration of the parent peptides was also found, suggesting a link between increased glucose concentration and oral microflora modification. Hypo-phosphorylation of statherin, Hst 1 and aPRPs (both entire and truncated isoforms) was found in a subset of patients with autism spectrum disorder [128] , suggesting asynchronies in the activation of the pleitropic Golgi-casein kinase acting in the CNS during the fetal growth of these subjects. All these studies are confirming that saliva, characterized by a non-invasive specimen collection, is an attractive bodily fluid for diagnostic purposes, with a particular concern to pediatric age [129] .
A minor contribution to whole saliva is ensured by gingival crevicular fluid, a transudate arising from the gingival plexus of gingival corium in minute quantities. Top-down platforms have evidenced that this fluid contains high concentrations of interesting peptides, such as α-defensins [130] , Tβ 4 and Tβ 10 [131] . The high amount of α-defensins probably originates from different leukocyte families transmigrating in high number in the gingival pocket, while the origin of the high levels of β-thymosins is currently unknown. Both peptides could modify their concentrations in several pathologies, offering new opportunities for early diagnosis of local and systemic diseases by this fluid.
Tears
Human tear is a fluid secreted from the lachrymal gland with several important functions, which beyond obvious humidification role include the prevention of infections and the ability to act as a barrier to the outside environment. Only few studies have been devoted to the characterization of peptides in tears. Nguyen-Khuong et al. used an LC-MALDI-TOF-MS approach to show the presence of small molecular weight compounds in human tears but no structural identification was carried out [132] . In another study performed on tears collected from patients suffering of xerophtalmia, large quantities of the antimicrobial α-defensins 1-3 were detected by electrophoretic separation and characterization by in-gel tryptic digestion/MALDI-TOF-MS analysis, suggesting the occurrence of chronic inflammation in the ocular regions [133] . Recently, a top-down comprehensive study on the human reflex tear fluid [134] revealed the presence of a great variety of novel naturally occurring peptides derived from PRP4 and the polymeric immunoglobulin receptor (pIgR). PRP4 is a protein whose mRNA is abundantly expressed in lachrymal acinar cells, also detected in submandibular, von Ebner's, sublingual, and parotid glands [135] . Many of the identified peptides showed an N-terminal pyroglutamate, which, as suggested by the authors, could contribute to preserve their structure in the tear fluid rich in proteases [136] . PIgR is an Fc receptor which facilitates the transcytosis of dimeric IgA and IgM to the apical surface. During epithelial transcytosis, pIgR is submitted to cleavage at the level of the extracellular domain, and the cleaved pIgR peptides are released either in a free form or associated with IgA or IgM [137] . Free peptides have been shown to possess innate antimicrobial properties [138] , and it has been also demonstrated that Fc receptors derived peptides show cytokine-like activity [139] . In this respect, it should be outlined that recent studies proved that the tear fluid contains chemosignal compounds [140] .
Miscellaneous

Seminal fluid
Seminal plasma is an acellular fluid providing a safe medium for spermatozoa. The ejaculate consists of up to 10% spermatozoa and 90% seminal plasma. Less than 1% of seminal plasma derives from urethral and bolbourethral (Cowper's) glands; 2-5% derives from testes, including the epididymis and vasa deferentia, whereas the 25-30% and 65-75% are of prostate and seminal vesicles, respectively [141, 142] . The secretion of the prostate represents the most important source of acid phosphatase, citric acid, inositol, calcium, magnesium and zinc present in the ejaculate. Seminal vesicles contain fructose, ascorbic acid, and prostaglandins. Epididymal secretions are rich in L-carnitine and neutral α-glucosidase, while a small amount of the seminal fructose originates from the ampulla of the ductus deferens [143] . The composition of the secretions from the different glands is used in the clinic to evaluate male fertility. Human seminal plasma is also a rich source of proteins that have important roles in the capacitation of the spermatozoa, modulation of the immune responses of the uterus, formation of the tubal sperm reservoir [144, 145] , and lastly in both the spermzona pellucida interaction and sperm-egg fusion [146, 147] . The diverse biomolecules content of seminal plasma allows the successful fertilization of the oocyte by the spermatozoa.
Immediately after the ejaculation, semen spontaneously coagulates into a semi-solid gelatinous mass due to the interactions between semenogelin I and II (SgI and SgII), the major coagulating proteins in human semen [148] [149] [150] .
Without proper semen liquefaction, men are frequently subfertile [151] . The liquefaction of semen, is a physiological process mainly connected to degradation of SgI and SgII by a prostate-derived kallikrein-like serine protease, called prostate-specific antigen, although other trypsin-like proteases originating from the prostate, such as human kallikrein hK2, prostatic acid phosphatase, transglutaminase and prostatin also contribute to the degradation of SgI and SgII at alternative sites [150, [152] [153] [154] .
Fung et al. characterized over 30 peptide components within unfractionated seminal plasma by means of MALDI-TOF-MS and LC-ESI-MS/MS approach, the majority of which were found to be proteolytic products of either SgI or SgII [155] .
It has been demonstrated that SgI and SgII and their related degradation peptides show biological functions such as antibacterial activity [156] [157] [158] or α-inhibin-like activity [159, 160] . Recently, some studies correlated naturally occurring peptides released by physiological cleavage of semen coagulum with the enhancement of HIV infection [161] [162] [163] [164] [165] .
Vitreous Humor
The human vitreous humor is the transparent highlyhydrated gel which occupies the posterior segment of the eye between the lens and the retina and it makes up about 80% of the volume of the eyeball [166] .
It is composed almost entirely of water (99%) with the remainder consisting of a mixture of collagen fibers, hyaluronic acid, hyalocytes, inorganic salts and lipids [167] .
The protein composition consists largely of albumin and other components like globulins, coagulation proteins, complement factors, and low-molecular-weight proteins [168] . The accumulation of proteins in the vitreous could be due to local secretion (e.g., glycoprotein), blood filtration (e.g., albumin), or diffusion from the surrounding tissues [169] . Since vitreous is in contact with the retina, physiological and pathological conditions of the retina itself could affect the protein and peptides composition within this fluid, especially when the blood-retinal barrier is disrupted [170] . Evidences show that changes of specific vitreous proteins are associated with various vitreoretinal diseases [171] [172] [173] and particularly in diabetic macular edema [174] or retinopathy [175] . Although several studies have been carried out with the aim to identify proteins differentially expressed in various pathologies, mainly by using techniques such as 2D electrophoresis coupled to MALDI-TOF, 2D electrophoresis coupled to LC-MS/MS [176, 177] or Difference Gel Electrophoresis (DIGE) [178, 179] , only few information is available about peptide composition of the vitreous humor. Rolling et al. [180] found significantly higher concentrations of atrial natriuretic peptide in vitreous humor of patients affected by active proliferative diabetic retinopathy (PDR) with respect to quiescent PDR and diabetes (without PDR) patients or controls by applying a specific and sensitive radioimmunoassay. They speculated that atrial natriuretic peptide, a 28-amino acid peptide hormone with natriuretic and vasodilatory properties [181] , contributes to the fibrovascular complications of PDR through possible direct antiangiogenic effects in the eye. No information is available on naturally occurring peptides detected by topdown analysis.
Pancreatic juice
Proteomic analysis of pancreatic juice was mainly focused on the research of chronic pancreatitis and pancreatic cancer biomarkers. In fact, as proximal bodily fluid, this juice is rich in proteins that are shed directly from the pancreas.
A priori, pancreatic juice should contain proteins from the zymogen granule content, plasma proteins from leak or transcytosis into ductal fluid, proteins shed from the apical membrane of acinar and ductal cells and intracellular proteins released because of damage either occurring in pathogenic states or during the collection process. The pancreatic juice is a not easily accessible bodily fluid and it is primarily collected during surgery or by endoscopic retrograde cholangio-pancreatography. Due to its collection invasiveness, few data are available about control subjects. The normal pancreatic juice proteome is therefore not yet fully understood. Up to date only one study was carried out by Doyle et al. [182] on normal pancreatic juice collected by retrograde cholangio-pancreatography from 3 females showing clinical abdominal symptoms but no apparent pancreatic pathology after investigation. Proteins were analyzed by a bottom-up approach losing the majority of the information about naturally occurring peptides. The largest group of proteins recognized was obviously digestive enzymes and plasma proteins. Studies to define proteins and peptides organellar localization, proteolysis processes, translocation, and PTMs with a topdown platform are necessary to provide more in-depth knowledge. Several studies were performed to characterize and quantify proteins and peptides in pancreatic juice of patients affected by pancreatitis and pancreatic cancer. In a preliminary work the proteins and peptides separation was carried out by means of 2-D electrophoresis followed by MALDI-TOF MS proteome characterization [183] [184] [185] [186] .
Grønborg et al. [187] used Sodium Dodecyl SulphatePolyAcrylamide Gel Electrophoresis (SDS-PAGE) followed by LC-MS/MS for the proteomic analysis of pancreatic juice (collected during surgery) from 3 patients with pancreatic adenocarcinoma. In addition to expected pancreatic proteins, they found a number of ''cancer-associated'' proteins including annexin 5, Carcinoembryonic antigenrelated cell adhesion molecule 5, and several S100 proteins.
Chen et al. [188] compared pancreatic juice from a chronic pancreatitis patient to a pooled sample from 10 ''normal'' subjects which have suffered of pancreatitis. Quantitation was carried out by using Isotope-Coded Affinity Tags (ICAT) labeling followed by 2-D LC-MS/MS. Proteins up-regulated in chronic pancreatitis included fibrinogen β chain, plasminogen/plasmin, Neural cell adhesion molecule L1, serum albumin, α 1b-glycoprotein, and α 2-macroglobulin. Some of these, however, have also been reported to be up-regulated in pancreatic cancer using the same approach [189] .
Several other studies were carried out for a comparative and/or quantitative analysis for biomarker discovery in pancreatic juice [190, 191] but completely lacked the issue of evaluating peptides without the constraint of assuming tryptic digestion. All this data should be confirmed and better understood using a top-down platform and a label-free quantization of natural occurring peptides and proteins.
Conclusions
As also outlined in the present review, peptides, being involved in key regulatory processes, play a central role in many physiological processes in living systems. Nevertheless, in the last twenty years the studies devoted to a comprehensive characterization of proteins and peptides in a tissue, cell or bodily fluid have been dominated by the throughput bottom-up techniques, which are intrinsically not suitable for the characterization of naturally occurring peptides. As a result significantly fewer "peptidomics" studies with respect to the "proteomics" ones are present in the literature. Even few, these studies demonstrated that important information can be obtained by the analysis of this subset of the proteome. For instance, the peptidomic characterization of bodily fluids provided valuable hints about the role played by specific proteinases under different physio-pathological conditions [127] , and disclosed new naturally occurring proteolytic cascades [112] . The consideration that processing patterns of peptides can be used for diagnostic purposes has represented an important stimulus for the exploration of endogenous peptides under pathological conditions.
On the whole the results described in this review demonstrate that the discovery of relevant biomarker candidates and drug targets is possible with top-down platform, often aided by bottom-up strategies and other enzymatic and chemical treatments. Given the rapid development in all the major technical aspects and the increasingly widespread application of top-down platforms, it is expected that peptidomics will give in the near future an important contribution in the field of drug discovery and biomarker characterization.
